1.A Case of Erythema Nodosum and Serositis Associated with Myelodysplastic Syndrome.
Jung Hye CHOI ; Myung Ju AHN ; Yong Wook PARK ; Ho Suk OH ; Young Yeul LEE ; In Soon KIM
The Korean Journal of Internal Medicine 2005;20(2):177-179
Myelodysplastic syndrome (MDS) is a heterogenous group of stem cell disorders usually characterized by progressive refractory cytopenias, which could progress to acute myeloid leukemia. MDS may be associated with a wide spectrum of skin lesions, including neoplastic cell infiltration, Sweet's syndrome, pyoderma gangrenosum, erythema elevatum diutinum, vasculitis, and panniculitis. However, erythema nodosum is rarely associated with MDS. Unusual rheumatologic manifestations in patients with MDS also have been reported, which range from asymptomatic serological abnormalities to classic connective tissue disorders such as Sjogren's syndrome, relapsing polychondritis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease. However, concurrent erythema nodosum and serositis has rarely been reported. We describe a case of MDS with erythema nodosum and immune-mediated pericardial effusion in a 34-year-old woman.
Adult
;
Biopsy
;
Diagnosis, Differential
;
Erythema Nodosum/*complications/diagnosis/drug therapy
;
Female
;
Follow-Up Studies
;
Glucocorticoids/therapeutic use
;
Humans
;
Myelodysplastic Syndromes/*complications/diagnosis/drug therapy
;
Prednisone/therapeutic use
;
Serositis/*complications/diagnosis/drug therapy
;
Tomography, X-Ray Computed
2.A Case of Autoimmune Hemolytic Anemia Complicating Hematopoietic Cell Transplantation.
Hyojin CHAE ; Yonggoo KIM ; Myungshin KIM ; Jihyang LIM ; Kyungja HAN ; Seok Goo CHO ; Jong Wook LEE
The Korean Journal of Laboratory Medicine 2008;28(1):64-69
A 32-yr-old male diagnosed with myelodysplastic syndrome underwent an unmanipulated, unrelated, HLA matched, peripheral blood stem cell transplantation. The patient and donor were both blood type O, CcDEe. Twelve weeks post-transplantation, he developed acute autoimmune hemolytic anemia (AIHA). He was transfused multiple times with washed O red cells. High-dose steroid therapy was initiated and he underwent splenectomy; however, AIHA was refractory to therapy. The patient was further treated with combined treatment modalities including immunosuppressive therapy with mycophenolate mofetil and cyclosporine and three cycles of plasma exchange, and AIHA responded to treatment. This is the third case of AIHA complicating hematopoietic stem cell transplantation reported in Korea. Since AIHA is relatively common after hematopoietic stem cell transplantation, accurate and timely diagnosis of the disease and treatment strategies with multiple modalities are necessary.
Adult
;
Anemia, Hemolytic, Autoimmune/*diagnosis/drug therapy/etiology
;
Combined Modality Therapy
;
Cyclosporine/therapeutic use
;
Hematopoietic Stem Cell Transplantation/*adverse effects
;
Humans
;
Male
;
Mycophenolic Acid/analogs & derivatives/therapeutic use
;
Myelodysplastic Syndromes/complications/diagnosis/therapy
;
Plasma Exchange